BIVI Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
5.7M
+6.2%
5.4M
-14.0%
6.3M
+18.5%
5.3M
+44.3%
3.7M
R&D
3.6M
+12.7%
3.2M
-25.6%
4.3M
+45.4%
2.9M
+139.8%
1.2M
SG&A
2.1M
-0.8%
2.2M
+11.1%
1.9M
-15.5%
2.3M
-3.8%
2.4M
Operating Income
-5719456
-6.2%
-5385377
+14.0%
-6262305
-18.5%
-5284595
-44.3%
-3663085
EBITDA
-5713148
-7.2%
-5328032
+14.1%
-6204961
-18.7%
-5227251
-45.0%
-3605741
Net Income
-5645532
-7.1%
-5270299
+13.2%
-6069475
-19.3%
-5087557
-45.8%
-3489141
EPS (Basic)
$-0.68
+2.9%
$-0.70
+9.1%
$-0.77
+21.4%
$-0.98
+48.1%
$-1.89
EPS (Diluted)
$-0.68
+2.9%
$-0.70
+9.1%
$-0.77
+21.4%
$-0.98
+48.1%
$-1.89
Shares (Diluted)
8.3M
+10.1%
7.5M
-4.8%
7.9M
+51.9%
5.2M
+182.3%
1.8M
BioVie (BIVI) โ€” Financials